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CASK Regulates SAP97 Conformation and Its Interactions
with AMPA and NMDA Receptors
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SAP97 interacts with AMPA receptors (AMPARs) and NMDA receptors (NMDARs) during sorting and trafficking to synapses. Here we
addressed how SAP97 distinguishes between AMPARs and NMDARs and what role the adaptor/scaffold protein, CASK, plays in the
process. Using intramolecular SAP97 Fo¨rster resonance energy transfer sensors, we demonstrated that SAP97 is in “extended” or
“compact” conformations in vivo. SAP97 conformation was regulated by a direct interaction between SAP97 and CASK through L27
protein-interaction domains on each protein. Unbound SAP97 was mostly in the compact conformation, while CASK binding stabilized
it in an extended conformation. InHEKcells and rat hippocampal neurons, SAP97 in the compact conformationpreferentially associated
and colocalized with GluA1-containing AMPARs, and in the extended conformation colocalized with GluN2B-containing NMDARs.
Altogether, our findings suggest a molecular mechanism by which CASK binding regulates SAP97 conformation and its subsequent
sorting and synaptic targeting of AMPARs and NMDARs during trafficking to synapses.
Introduction
AMPA receptor (AMPAR) and NMDA receptor (NMDAR) traf-
ficking at postsynaptic densities (PSDs) is critical for the devel-
opment, function, and plasticity of excitatory synapses. SAP97 is
a member of the family of PSD-95-like membrane-associated
guanylate kinases (PSD-MAGUKs). PSD-MAGUKs are scaffold
proteins that regulate AMPAR and NMDAR trafficking and
numbers at PSDs (Elias and Nicoll, 2007; Xu, 2011). The major
isoform of SAP97, SAP97, contains an N-terminal L27 domain,
which interacts with other L27 domain-containing proteins, in
particular, CASK (Lee et al., 2002). Small numbers of a different
SAP97 isoform with an alternative N-terminal domain, SAP97,
also exist in neurons (Waites et al., 2009). In this study, we only
assay the SAP97 isoform, referred to as “SAP97” throughout.
SAP97 directly associates with AMPARs and NMDARs early
in the secretory pathway (Sans et al., 2001; Jeyifous et al., 2009)
via the GluA1 and GluN2A/B PDZ-binding motifs and SAP97
PDZ domains 1 and 2 (Leonard et al., 1998). AMPARs and
NMDARs are sorted from each other at the endoplasmic reticu-
lum (Jeyifous et al., 2009) and trafficked from soma to synapses in
distinct complexes. SAP97 trafficks with AMPARs andNMDARs
on vesicles that move along dendritic microtubules (Setou et al.,
2000, 2002) at different rates (Washbourne et al., 2002; Perest-
enko and Henley, 2003). In addition to SAP97, AMPAR and
NMDAR complexes contain different adapters and motors
(Setou et al., 2002). Previously, we found that SAP97-CASK in-
teractions are critical for sorting NMDARs from AMPARs, that
SAP97 and CASK colocalize in complexes with NMDARs in
KIF17-containing transport vesicles in dendrites, and that
SAP97, but not CASK, is critical for AMPAR trafficking (Jeyifous
et al., 2009). Here, we address how SAP97 distinguishes between
the receptor subtypes and the differential role of CASK.
An unexplored possibility is that SAP97 conformational
changes regulate their associations with glutamate receptor sub-
types. There is significant evidence of different SAP97 conforma-
tions in vitro. Intramolecular interactions betweenPSD-MAGUK
SH3 andGUKdomains regulate GUK affinity for its ligands (Mc-
Gee et al., 2001; Tavares et al., 2001). Molecular modeling sug-
gests that SAP97 domains are stable in multiple conformational
states (Wu et al., 2000) and single particle electron microscopy
(EM) revealed SAP97 in both “extended” rod-like and “compact”
C-shaped structures (Nakagawa et al., 2004). Using dynamic
measurements in vitro, a truncated version of SAP97was found in
both compact and extended conformations, in dynamic equilib-
rium between the two states (Tully et al., 2012). Together, the
data raise the possibility that SAP97 function is regulated by con-
formational changes in vivo.
To detect changes in SAP97 conformation in vivo, we gener-
ated Fo¨rster resonance energy transfer (FRET) biosensors by fus-
ing a pair of FRET probes to theN andC termini of SAP97. Using
this FRET sensor, we show that SAP97 is in different conforma-
tions when bound to AMPARs or NMDARs in HEK cells or in
transport vesicles in neurons. SAP97 was in the compact confor-
Received Feb. 21, 2013; revised June 9, 2013; accepted June 14, 2013.
Author contributions: E.I.L., O.J., andW.N.G. designed research; E.I.L. and O.J. performed research; E.I.L. and O.J.
analyzed data; E.I.L., O.J., and W.N.G. wrote the paper.
This work was supported by the U.S. National Institutes of Health (NIH) under grant numbers NS043782,
MH081251, and DA019695 (W.N.G.). This project was also supported by the National Center for Research Resources
and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant
Number UL1 RR024999 (O.J.) and faculty fellowships from theMarine Biological Laboratory. We are grateful to Drs.
Anitha Govind, Sarah Antinone, Jason Schumer (University of Chicago), and Xiaobing Chen and Tom Reese (NIH/
National Institute of Neurological Disorders and Stroke) for their critical reading and helpful comments on this
manuscript.We thank Vytas Bindokas and Paul Selvin for their technical support with FRET experiments and Shohei
Koide for his assistance in generating the SAP97 L27 mutant.
The authors declare no competing financial interests.
*E.I.L. and O.J. contributed equally to this work.
Correspondence should be addressed to William N. Green, Department of Neurobiology, University of Chicago,
Chicago IL 60637. E-mail: wgreen@bsd.uchicago.edu.
DOI:10.1523/JNEUROSCI.0816-13.2013
Copyright © 2013 the authors 0270-6474/13/3312067-10$15.00/0
The Journal of Neuroscience, July 17, 2013 • 33(29):12067–12076 • 12067
mation when colocalized with GluA1-containing AMPARs, and
in the extended conformation when colocalized with GluN2B-
containing NMDARs. An interaction between SAP97 and CASK
changes SAP97 conformation from compact to extended. Our
findings explainwhyCASK selectively colocalizedwithNMDARs
and SAP97 in transport vesicles, and why knockdown of SAP97
impaired trafficking of AMPARs and NMDARs but CASK
knockdown only affected NMDAR trafficking (Jeyifous et al.,
2009). Overall, our results provide new insights into how changes
in SAP97 conformation regulate their function and reveal how
CASK binding alters SAP97 conformation and controls its inter-
actions with AMPARs and NMDARs.
Materials andMethods
Culture of HEK293 cells and primary hippocampal neurons
HEK293 cells were maintained in DMEM supplemented with 10%
calf serum (HyClone). Cells were transiently transfected with cDNA
using a calcium phosphate protocol (Claudio, 1992). Cells transfected
with HA-GluR1 or HA-NMDAR were maintained in media contain-
ing 1 mM kynurenic acid (Sigma) or 100 M D()-2-amino-5-
phosphonovaleric acid (Sigma) and 10 M MK-801 (RBI), respectively,
to prevent excitotoxicity.
Hippocampal cultures were prepared using Neurobasal medium, 2%
(v/v) B27, and 2 mM L-glutamine. Briefly, hippocampi from embryonic
(E18–E19) Sprague Dawley rats of either sex were dissected, dissociated
in 0.05% trypsin (v/v; Invitrogen), and cells were plated at a density of
4 105 cells/ml on polyethylenimine-coated 12 mm coverslips. Cov-
erslips weremaintained inNeurobasal medium containing B27 andGlu-
taMAX (all from Invitrogen).
Neuronal cultures were transfected at 12–14 days in vitro (DIV) with
the Lipofectamine 2000 transfection reagent (Invitrogen) according to
manufacturer’s recommendations, with the exception that 1–2.5 g of
each cDNA in 62.5 l of Neurobasal media and 2.5 l of Lipofectamine
2000 in 62.5l of Neurobasal media were mixed and added to coverslips
in 12-well plates.
Antibodies and reagents. The following antibodies were used: anti-
Bassoon antibody (Synaptic Systems), anti-NR2B antibody (BD Biosci-
ences), anti-GluR1 antibody (Calbiochem), anti-HA (rabbit polyclonal)
antibody (Bethyl Laboratories), anti-Myc 9E10 antibody (Santa Cruz
Biotechnology), anti-GFP antibody (Sigma-Aldrich), and anti-RFP an-
tibody (MBL International). Alexa Fluor anti-mouse 488/568/647/750
and Alexa Fluor anti-rabbit 647/750 were purchased from Invitrogen.
Plasmids and transfections.RatGluN1 andGluN2Bwere obtained from J.
Boulter (University of California, Los Angeles). GluN1 and GluN2B sub-
units were tagged at the NH2 terminus with the FLAG (DYKDDDDK) and
HA (YPYDVPDYA) epitopes respectively using the extension overlap PCR
method (Hoet al., 1989) and subcloned into apCB6mammalian expression
vector. Monomeric cherry (Ch)-tagged GluA1 was a gift from C. Garner
(Stanford University, Stanford, California). Myc-CASK and Myc-
CASKL27N were gifts from B. Margolis (University of Michigan). Con-
struction ofGFP-SAP97 (splice variant I1b, I3, and I5) has been previously
described (Wu et al., 1998; Bresler et al., 2004). To generate Ch-SAP97-V,
Ch-SAP97, and SAP97-V, EcoRI restriction enzyme sites were placed on the
N and C termini of mCherry and KpnI sites were placed on the N and C
termini ofVenususingPCR.UsingEcoR1 andKpnI,mCherry and/orVenus
were subcloned into SAP97 in pEGFP-N1 and screened for correct direc-
tional insertion. To generate Ch-SAP97-V-L15K, amino acid residue 15was
mutated fromUUG to AAG using QuikChange (Invitrogen).
Immunostaining and image analysis. HEK293 cells and neuronal cul-
tures (24 h post-transfection)werewashed twice in PBS at 22–25°C, fixed
in 4% paraformaldehyde (PFA)/sucrose (v/v, room temperature, 10
min), and washed three times in PBS (5–10 min). For permeabilization,
cells were incubated in 0.1% Triton-X in PBS (10 min), incubated in
blocking solution (2% glycine (w/v), 2% bovine serum albumen (w/v),
0.2% gelatin (w/v), and 50 mM NH4Cl in PBS; 10 min) and then incu-
batedwith the indicated primary antibody diluted in blocking solution (1
h). Following primary antibody incubation, cells were washed three
times in blocking solution (5–10 min) and overlaid with an appropriate
secondary antibody diluted in blocking solution (1 h). Cells were then
washed three times in PBS (5–10 min) and the slips mounted in 80%
glycerol or Prolong Gold (Invitrogen). Fluorescence images were ac-
quired using a Leica SP5 Tandem Scanner Spectral 2-photon scanning
confocalmicroscope (LeicaMicrosystems). Images were processed using
ImageJ (National Institutes of Health, Bethesda, MD) and Adobe Pho-
toshop software.
Calculation of FRET efficiency. Images were acquired using a Leica SP5
laser scanning confocal microscope operating with an argon laser tuned
to 514 nm, aDPSS laser tuned to 561 nm, and anHeNe laser line tuned to
633 nm. Cells were examined with a 63 1.4 NA (Leica) oil-immersion
objective and 4 zoom. FRET was measured using the acceptor photo-
bleaching method (Kenworthy, 2001). Cells were bleached in the
mCherry channel by scanning a region of interest 5–10 times using the
561nmDPSS laser line at 100% intensity. The time of bleach ranged from
3 to 10 s depending on the size of the region of interest (ROI) for bleach-
ing. For HEK293 cells, a scanning speed of 800 Hz was used to maximize
the degree of acceptor bleaching at each step. For neurons, a scanning
speed of 8000 Hz was used. Before and after each bleach step, Venus
images were collected to assess changes in donor fluorescence. Because
increases in Venus fluorescence caused by bleaching of the mCherry
acceptor could potentially be masked by bleaching of Venus related sim-
ply to the imaging process itself, the effect of photobleaching due to
imaging was minimized by collecting Venus images at 1% of the laser
intensity. To ensure that bleaching due to imaging was minimal, we
monitored the level of bleaching in each experiment by collecting five
images of the donor (Venus) before bleaching. The gain of the photo-
multiplier tubes was adjusted so as to eliminate cross talk and to achieve
the best possible dynamic range.
To calculate the FRET energy transfer efficiency (ET), we used the
following formula:
ET (1 Ida/Id)
where Ida and Id are the fluorescence intensities of the donor in the
presence and absence of acceptor, respectively. To obtain these values,
fluorescence intensities were analyzed using ImageJ software and donor
fluorescence variations were plotted against acceptor depletion over suc-
cessive bleaching steps. The slope of the linear relationshipwas used to Ida
and Id. As a reference, fluorescence of analogous peptides with only a
donor, only an acceptor, or both were measured to control for both
pseudo-FRET artifacts and intermolecular FRET. Average distance (r)
between donor and acceptor was calculated using the following formula:
r R0(ET
 1 1) 1/6
whereR0 is the Fo¨rster distance corresponding to 57 Å for our Venus and
mCherry sensors. This calculation assumes a random orientation factor
( 2 2/3).
To prepare HEK293 cells for FRET analysis, cells were fixed in 4%
PFA/sucrose, washed in PBS, and mounted in 80% glycerol. To define
ROIs with cell markers (i.e., AMPARs, NMDARs, presynaptic markers,
etc.), immunolabeling was performed with primary antibody, washed
three times, and labeled with an Alexa 647- or Alexa 750-conjugated
secondary antibody, which was imaged on the Far Red or Far Far Red
channel at the end of a photobleaching protocol. Images of thesemarkers
were used to create a mask to isolate regions for FRET analysis.
Argon lasers (514 and 568 nm) were used to excite Venus and
mCherry, respectively (spectral channel settings: donor, 535 nm  10
nm; acceptor 610 nm  25 nm). Low resonant scanning at 800 Hz was
used in HEK293 cell experiments while high-resonant scanning at 8000
Hz was used for neuron experiments.
Immunoprecipitation and immunoblot analysis. Cells were pelleted by
brief centrifugation, resuspended,washed oncewith PBS, and solubilized
in lysis buffer (150 mM NaCl, 5 mM EDTA, pH 7.4, 50 mM Tris, pH 7.4,
0.02%NaN3) containing 1%TritonX-100NEM(2mM), phenylmeth-
anesulfonyl fluoride (2 mM), leupeptin (10 g ml1), N-tosyl-Lys-
chloromethyl ketone HCl (10 g ml1), chymotrypsin (10 g ml1), and
pepstatin (10 gml1). Following a 1 h solubilization (4°C), samples were
centrifuged at 14,000  g for 30 min at 4°C. Subsequent analyses were
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performed using the Triton X-100-soluble fraction. Immunoprecipi-
tations were performed by overnight antibody incubation at 4°C.
Protein-antibody complexes were isolated by incubation with Protein
G–Sepharose for 3 h at 4°C.
For immunoblotting, proteins separated by SDS-PAGE were trans-
ferred to PVDF membranes. After transfer, the PVDF was blocked
with 3% milk in wash buffer (10 mM Tris, pH 7.4, 0.05% Tween 20
(w/v), and 150 mM NaCl). Membranes were washed briefly in wash
buffer and then incubated for 1 h with primary antibodies. The blots
were washed and incubated with secondary antibody (goat antibody
to mouse, rabbit, or chicken Alexa 488, 568, or 647) at the appropriate
dilution for 1 h. After washing, membranes were imaged on Bio-Rad
Molecular Imager Pharos-FX. Quantification was done using ImageJ.
Statistical analysis
Results are expressed asmean SEMof n sam-
ples unless stated otherwise. Statistical signifi-
cance was assessed by a two-tailed Student’s t
test or ANOVA as appropriate.
Results
Generation of SAP97 FRET sensor to
detect conformational changes
SAP97 is required for sorting NMDARs
fromAMPARs in the endoplasmic reticu-
lum (ER; Jeyifous et al., 2009) and inter-
acts directly with both NMDARs and
AMPARs (Sans et al., 2001; Elias and Ni-
coll, 2007; Jeyifous et al., 2009). Our goal
was to understand how SAP97 distin-
guishes between AMPARs and NMDARs
and whether this involves different con-
formations of SAP97 that have previously
been reported (Nakagawa et al., 2004). To
assay for changes in SAP97 conformation,
we generated SAP97 fusion constructs
by adding fluorescent proteins that
form a FRET pair to the N and C termini
of SAP97 (Ch-SAP97-V; Fig. 1a). A
mCherry and Venus fluorophore were se-
lected as an acceptor and donor pair. To
assay for FRET, we performed an acceptor
photobleaching protocol on Ch-SAP97-V
(Fig. 1b,c) from which we obtained FRET
efficiency values (Fig. 1c, inset). The pro-
tocol measured increases in Venus fluo-
rescence (donor; Fig. 1b, middle and
bottom) after successive photobleaching
of mCherry (acceptor; Fig. 1b, top). The
increase in donor fluorescence, which is
best visualized by pseudocolorization of
the donor fluorescence (Fig. 1b, bottom),
is a quantitative measure of FRET based
on the blocking of donor fluorescence
quenching caused by FRET. The percentage
change in donor fluorescence increased lin-
early as the acceptor fluorescence decreased
(Fig. 1c). The FRET efficiency, 13.5%, was
calculated from the fit to the values of the
fluorescence changes. Importantly, no
FRET was observed when the FRET pairs
were attached separately to the N or C ter-
mini of SAP97 (Ch-SAP97 and SAP97-Ve-
nus; Fig. 1a) and expressed together in
HEK293 cells (Fig. 1c). The FRETmeasured
using Ch-SAP97-V is, therefore, intramo-
lecular and does not result from intermolecular FRET between two
or more SAP97 molecules. These results also indicate that donor
photoactivation, which can sometimes occur during acceptor pho-
tobleaching, is not contributing to the FRET measurements (Kar-
pova andMcNally, 2006). If we assume a randomorientation factor
for FRET pairs, the FRET efficiency value corresponds to a distance
between FRETpairs of77Å,which is consistent with previous EM
studies of SAP97 in the compact conformation (Nakagawa et al.,
2004). Similar values for the FRET efficiency were obtained when a
different SAP97 FRET sensor that used Venus and ECFP as a FRET
pair (Venus-SAP97-ECFP; data not shown) was assayed.
Figure 1. An intramolecular FRET sensor designed to assay SAP97 conformation. a, Schematic of SAP97 FRET sensor, Ch-
SAP97-V, and FRET sensor controls, Ch-SAP97 and SAP97-V. b, Representative images of a photobleachingmethod performed on
Ch-SAP97-V in HEK293 cells to obtain Ch-SAP97-V FRET efficiency. Venus andmCherry fluorescence images were acquired before
and after six acceptor photobleaching steps. Bottom row displays Venus (donor) pseudocolor intensity. Scale bar, 10 m. c,
Ch-SAP97-V FRET efficiency determined from the linear relationship between increases in donor (mCherry) fluorescence with
decreases in acceptor (Venus) with photobleaching. The photobleaching steps for Ch-SAP97-V in b are plotted as the percentage
decrease in acceptor intensity versus the percentage increase in donor intensity (F). A corresponding rise in donor intensity is not
observedwhen Ch-SAP97 is coexpressedwith SAP97-V (E). Inset, FRET efficiency values, ET, were calculated from the data above
using the equation: ET (1 – Ida/Id), where Ida and Id are the fluorescence intensities of the donor in the presence and absence of
acceptor, respectively. FRET efficiency for Ch-SAP97-V is 13.5 1% (mean SEM; n 34 cells, *p 0.01) compared with
0.8 1.8% (mean SEM; n 15 cells) in cells coexpressing Ch-SAP97 and SAP97-V.
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SAP97 is in different conformations when interacting with
AMPARs and NMDARs
In neurons, SAP97 and GluA1 co-cluster in puncta on the cell
surface and in an intracellular compartment (Sans et al., 2001).
Similar cell surface and intracellular puncta containing Ch-
SAP97 and GluA1 subunits are observed when expressed in
HEK293 cells (Jeyifous et al., 2009). We observed identical colo-
calizing cell-surface and intracellular puncta for the FRET sensor,
Ch-SAP97-V, with GluA1 subunits inHEK293 cells (Fig. 2a).We
assayed Ch-SAP97-V FRET when colocalized in small intracellu-
lar (Fig. 2a, top) or cell-surface clusters (Fig. 2a, bottom) with
GluA1-containing AMPARs, assuming that Ch-SAP97-V and
GluA1 subunits in the clusters are complexed. There was a small
difference in Ch-SAP97-V FRET in these clusters compared with
Ch-SAP97-V without AMPAR colocalization (Fig. 1), but the
difference was not statistically significant. The FRET efficiency
for theCh-SAP97-V sensor alone was 13.5% (Fig. 1) and 14.4%
when clustered with AMPARs at the cell surface (Fig. 2a,c).
In HEK293 cells, interactions between SAP97 and GluN2B
subunits cause intracellular clusters of SAP97 and NMDARs to
form in the ER, which prevent NMDAR trafficking to the cell
surface (Jeyifous et al., 2009).We observed the same intracellular
clusters when the FRET sensor, Ch-SAP97-V, was coexpressed
with NMDAR subunits (Fig. 2b). When complexed with
NMDARs at these intracellular clusters, the FRET efficiency of
Ch-SAP97-V significantly decreased to 2.6% compared with
13.5% when alone (Fig. 2b,c). The decreased FRET efficiency of
SAP97 to near 0% when associated with NMDARs is consistent
with a conformation that places its N and C termini at or beyond
100 Å apart in an “extended” conformation as observed by EM
single particle measurements (Nakagawa et al., 2004). This result
indicates that SAP97 changes from a compact to extended con-
formation before or during associations with NMDARs. We ob-
tained almost identical results in HEK293 cells with the different
SAP97 FRET sensor (Venus-SAP97-ECFP; data not shown).
Next, we expressedCh-SAP97-V in primary hippocampal cul-
tured neurons (Fig. 2d). In the somata, Ch-SAP97-V labeled
reticulated membrane, consistent with previous findings of
endogenous SAP97 in the ER (Fig. 2d, left). In dendrites, we
observed Ch-SAP97-V in two classes of puncta that we had pre-
viously observed for endogenous and transfected SAP97 (Jeyi-
fous et al., 2009). Large puncta containing Ch-SAP97-V were
observed in spine-like structures that colocalized with the pre-
synaptic marker, bassoon (Fig. 2d, middle and right), consistent
with a postsynaptic localization for Ch-SAP97-V. Smaller, non-
synaptic puncta were also observed in the dendritic shafts (Fig.
2d, right). We had previously found that SAP97 in these smaller
puncta were mobile vesicles, some of which contained NMDARs
(Jeyifous et al., 2009). These smaller puncta in the shafts of den-
drites contain AMPARs or NMDARs in separate vesicles (Wash-
bourne et al., 2002) and SAP97 interacts with GluA1-containing
AMPARs (Leonard et al., 1998) orGluN2B-containingNMDARs
(Jeyifous et al., 2009).
To examine SAP97 conformation in neurons when colocal-
ized with NMDARs or AMPARs, we analyzed the smaller puncta
in the shafts of dendrites. Endogenous NMDARs or AMPARs
were labeledwith anti-GluA1 or anti-GluN2B antibodies, respec-
tively (Fig. 2e,f). In these cultures, 20% of immunolabeled
GluA1 puncta appeared to be synaptic based on colocalization
with the presynaptic marker, bassoon. The other 80% of GluA1-
containing puncta were nonsynaptic and we assumed they are
mostly transport vesicles. The SAP97 FRET efficiency measured
at puncta that colocalized with GluA1 was 27.2%, significantly
higher than the 5.2% measured at puncta that did not colocalize
with GluA1 (Fig. 2e,g). We obtained completely opposite FRET
results for Ch-SAP97-V puncta that either colocalized or did not
colocalize with anti-GluN2B antibodies. For puncta with
GluN2B subunits, the SAP97 FRET efficiency was 3.5% com-
pared with 26.2% for puncta that did not colocalize with GluN2B
subunits (Fig. 2f,g). Thus, our findings in neurons are consistent
with the results inHEK293 cells and indicate that SAP97 is primarily
in the compact conformation when associated with AMPARs in
transport vesicles, and in the extended conformation when associ-
ated with NMDARs in transport vesicles.
CASK binding to SAP97 triggers a transition to the
extended conformation
During normal NMDAR trafficking in cultured hippocampal
neurons, NMDARs are bound by SAP97 through a PDZ domain
interaction, and SAP97 is bound by CASK through L27 domains
on each protein (Lee et al., 2002; Jeyifous et al., 2009). AMPAR
trafficking also requires a PDZ domain interaction with SAP97
(Sans et al., 2001), but does not appear to be bound by CASK
(Jeyifous et al., 2009). These findings prompted us to study
whether CASK binding to SAP97 could be a determinant in al-
tering SAP97 conformation and regulating whether it interacts
with AMPARs or NMDARs. We coexpressed Ch-SAP97-V and
Myc-taggedCASK (Myc-CASK; Fig. 3a) inHEK293 cells (Fig. 3b,
third row) andmeasured SAP97 FRET at the cell surface where it
colocalizes with CASK. CASK significantly decreased Ch-
SAP97-V FRET efficiency to 2.6% (Fig. 3c) comparedwith 13.5%
when Ch-SAP97-V was expressed alone (Fig. 3b, top row). A
similar decrease caused by CASK was also observed using a dif-
ferent Venus-SAP97-ECFP FRET sensor (data not shown). In
both cases, the loss of FRET to near 0% indicates that coexpres-
sion with CASK causes SAP97 to change its predominant confor-
mation from the compact to the extended form.
Next, we examined whether the decrease in Ch-SAP97-V
FRET with CASK coexpression occurred through a direct inter-
action between CASK and SAP97. Previous studies concluded
that the SAP97-CASK interaction is an L27 domain association
between the L27 domain at the N terminus of SAP97 and the first
of two L27 domains (L27N) onCASK (Lee et al., 2002).We tested
whether a CASK construct in which the first of its two L27
domains was truncated (Myc-CASKL27N; Fig. 3a) pre-
vented the SAP97-CASK interaction. When we coexpressed
Myc-CASKL27Nwith Ch-SAP97-V inHEK293 cells we did not
observe colocalization between SAP97 and CASKL27N at the
plasma membrane, which we observed when Ch-SAP97-V was
coexpressed with full-length CASK (Fig. 3b). We also could not
coimmunoprecipitate Ch-SAP97-V with Myc-CASKL27N
while Ch-SAP97-V coimmunoprecipitated with full-length
CASK (Fig. 3d). As a second test of the SAP97-CASK interaction,
we introduced a more subtle change in the Ch-SAP97-V L27
domain to disrupt the L27 domain interaction. Based on the
high-resolution NMR structure of the interacting SAP97 and
CASKL27domains (Feng et al., 2004), we predicted that a leucine
residue (L15) in a hydrophobic binding surface of the SAP97 L27
domain, when mutated to a lysine residue (L15K-Ch-SAP97-V),
would disrupt the L27 interaction between SAP97 and CASK.
Similar to the Myc-CASKL27N truncation, the L15K-Ch-
SAP97-Vmutation did not colocalizewithCASK inHEK293 cells
(Fig. 3b) nor did it coimmunoprecipitate with CASK (Fig. 3d).
When Ch-SAP97-V was coexpressed with CASKL27N in-
stead of CASK, the decrease in Ch-SAP97-V FRET was no longer
observed, consistent with the FRET decrease being caused by an
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Figure 2. SAP97 is in different conformations when associated with NMDARs and AMPARs. a, Images from HEK293 cells coexpressing Ch-SAP97-V and HA-tagged AMPARs (HA-GluA1).
Intracellular (boxed region, top) and cell-surface (boxed region, bottom) clusters of SAP97 andAMPARswere assayed. Cell-surface clusters of HA-GluA1-containingAMPARswere labeled by staining
intact cells to the extracellular HA-GluA1 epitope with anti-HA antibodies. Regions of apparent AMPAR-SAP97 interactions were identified by colocalization of SAP97 fluorescence with staining for
HA-tagged GluA1 subunits with anti-HA antibodies (green). The initial and final (pre- and post-bleached) Venus andmCherry fluorescence signals are displayed for Ch-SAP97-V during an acceptor
photobleachingexperiment. Scalebar, 10m.b, Images fromHEK293cells coexpressingCh-SAP97-VandHA-andFlag-taggedNMDARs (HA-GluN2BandFlag-GluN1). Intracellular clusters of SAP97
andNMDARs (boxed regions)were assayedand identifiedby colocalizationof SAP97 fluorescencewith staining for Flag-taggedGluN1 subunitswith anti-Flag antibodies (green). The initial and final
(pre- and post-bleached) Venus and mCherry fluorescence signals are displayed for Ch-SAP97-V during an acceptor photobleaching experiment. Scale bar, 10m. c, Ch-SAP97-V FRET efficiency
values at NMDAR or AMPAR clusters. The FRET efficiency of Ch-SAP97-V in AMPAR clusters was 14.4 1.2% (mean SEM; n 18 cells) and 2.6 1.8% (mean SEM; n 20 cells, *p 0.01)
in NMDAR clusters. Only the FRET efficiency values for Ch-SAP97-V in NMDAR clusters was significantly different from the FRET efficiency value of 13.5 0.8% for Ch-SAP97-V expressed alone in
HEK293 cells.d, Dual fluor tagging of SAP97 does not disrupt normal neuronal targeting and localization of the protein. Hippocampal neurons (16 DIV) transfectedwith cDNA encoding Ch-SAP97-V.
Left, Somatic expression of the FRET sensor. The perinuclear and ER-like localization is identical to that reported for endogenous SAP97.Middle, Ch-SAP97-V is observed throughout dendritic shafts,
with an obvious accumulation in postsynaptic spines (colocalization with the presynaptic protein, Bassoon), as reported for SAP97. Right, Higher magnification images displaying Ch-SAP97-V in
large, synaptic (arrowheads) puncta, and also in small, nonsynaptic (arrows) puncta that may represent trafficking vesicles. e, The FRET efficiency of Ch-SAP97-V colocalized with AMPARs in
dendrites. Left, Images of dendrites from cultured hippocampal neurons (E18, 14 DIV) transfected with Ch-SAP97-V and immunolabeled with anti-GluA1 antibodies to detect endogenous GluA1
colocalized with Ch-SAP97-V (Ch-SAP97-V fluorescence, top; anti-GluA1, middle; merged image, bottom). Scale bar, 10m. Middle, Expanded images of Ch-SAP97-V puncta that colocalize with
GluA1 (arrow) or do not colocalize. Right, An example of analysis of the donor fluorescence intensity profiles taken through the yellow line in the middle images. Intensity profiles were acquired
before (pre; solid line) and after (post; dashed line) acceptor photobleaching. FRET changes were only observed for Ch-SAP97-V puncta colocalized with GluA1. Scale bar, (Figure legend continues.)
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L27-L27 domain interaction between CASK and SAP97. Simi-
larly, the decrease in Ch-SAP97-V FRET caused by CASK was in
large part not observed when L15K-Ch-SAP97-V replaced Ch-
SAP97-V.We did observe a small decrease in L15K-Ch-SAP97-V
FRET by CASK suggesting that the interaction between L15K-
Ch-SAP97-V and CASK was not totally eliminated by the SAP97
mutation. These results suggest that the interaction between the
L27N domain of CASK and the L27 domain of SAP97 triggers
SAP97 to change its conformation from the compact to the ex-
tended conformation. Based on these results, we predicted that
the addition of CASK toHEK cells expressing SAP97 and GluA1-
containing AMPARs should have a significant effect on SAP97-
AMPAR interactions. Specifically, we predicted that the addition
of CASK should highly reduce the coimmunoprecipitation of
GluA1 subunits with SAP97, if SAP97 conformation changes
largely from the compact to extended conformation. Consistent
with the prediction, we found in HEK cells that CASK coexpres-
sion reduced the coimmunoprecipitation ofGluA1 subunits with
SAP97 by 84% compared with coimmunoprecipitation of GluA1
subunits and SAP97 in the absence of CASK (Fig. 3e).
Other post-translational modifications alter
SAP97 conformation
In experiments where SAP97 was expressed in HEK293 cells, the
FRETmeasurementswere largely consistentwith FRETmeasure-
ments in neurons. However, we found unexpected differences in
the peak FRET valuemeasured for the compact conformations of
SAP97 in HEK293 cells compared with cultured neurons (Fig. 3f,
left). Because of the precision of our FRETmeasurements, we felt
it unlikely that the differences in FRET measurements between
neurons andHEK293 cells were an artifact. Rather, there appears
to be a difference in the SAP97 compact conformation when
expressed in HEK293 cells versus neurons. Therefore we tested
whether additional post-translational modifications could ac-
count for the difference observed between the two cell types using
the SAP97 FRET sensor.
CaMKII phosphorylates the L27 domain (residue S39) and
PDZ1 domain (residue S232) of SAP97, which inhibits its inter-
actions with GluN2A (Gardoni et al., 2003; Mauceri et al., 2007).
AKAP, GKAP, and L27 proteins such asMyoVI are also known to
interact with SAP97 and regulate AMPAR trafficking (Nash et al.,
2010; Colledge et al., 2000). To address whether CaMKII activity
could influenceCh-SAP97-V conformational state, we compared
the FRET efficiency when Ch-SAP97-V was coexpressed with
autophosphorylation-deficient CaMKII-T286A, which decreases
CaMKII activity, or phosphomimetic CaMKII-T286D, which
causes CaMKII to bemore active (Fig. 3f, right). InHEK293 cells,
CaMKII-T286A significantly lowered the FRET efficiency of Ch-
SAP97-V while CaMKII-T286D significantly increased FRET ef-
ficiency. These results suggest that phosphorylation of SAP97 by
CaMKII might contribute to the alteration of SAP97 conforma-
tion in vivo, but in a more subtle way than the binding and un-
binding of CASK, perhaps by modulating the position of the N
and C termini relative to each other when in the compact confor-
mation. Because the FRET efficiency values are so low when Ch-
SAP97-V is in the extended conformation, we are unlikely to
measure these differences. The finding that CaMKII phosphory-
lation of SAP97 weakens its interaction with NMDARs (Gardoni
et al., 2003) suggests that CaMKII phosphorylation of SAP97
when bound by CASK may also modulate SAP97 conformation
when it is in the extended conformation.
Discussion
SAP97 and CASK are required for the sorting of AMPARs and
NMDARs during their trafficking in dendrites (Jeyifous et al.,
2009), but the mechanistic details about how they differentially
interact with the receptor subtypes are poorly characterized. In
this study, we have tested whether changes in SAP97 conforma-
tion have a role in the ability of SAP97 to discriminate between
AMPARs and NMDARs. To assay for SAP97 conformation, we
engineered an intramolecular SAP97 FRET sensor that allowed
us tomeasure and distinguish SAP97 extended and compact con-
formations in vivo. Previous evidence that SAP97 undergoes dy-
namic changes between compact and extended conformations in
vitro comes from a small-angle, x-ray scattering study on a trun-
cated version of SAP97 (Tully et al., 2012). In the present study,
we demonstrate that SAP97 exists in extended and compact con-
formations in vivo, and that it is in the extended conformation
when NMDAR bound, and in the compact conformation when
AMPAR bound. Previously, we had observed that knockdown of
either SAP97 or CASK altered the sorting of NMDARs from
AMPARs, but knockdown of SAP97, and not CASK, altered
AMPAR trafficking (Jeyifous et al., 2009). Consistent with these
data, we find that the L27 domain-mediated interaction between
SAP97 andCASK stabilizes SAP97 in the extended conformation,
the conformation in which it preferentially interacts with
NMDARs. The levels of CASK and the degree towhich it is bound
to SAP97 appear to regulate whether SAP97 binds to NMDARs or
AMPARs. In addition to CASK binding, SAP97 conformation was
modulated by altering the levels of CaMKII activity. Thus, there
appear to be multiple methods by which SAP97 conformation is
regulated, and thereby, whether it binds to NMDARs, AMPARs, or
other binding partners.
In Figure 4, we propose a model to explain how dynamic
conformational changes of SAP97 in vivomediate the sorting and
synapse-specific targeting of AMPARs and NMDARs during
their trafficking in dendrites. As shown in Figure 4a, we assume
that SAP97 is in dynamic equilibrium between its compact and
extended states in vivo. When not bound by CASK, it resides
primarily in its compact state and can interact with GluA1-
containing AMPARs, but not appreciably with GluN2B-
containingNMDARs in the ER.When the SAP97N terminal, L27
domain binds CASK at its L27N domain, it stabilizes it in its
extended conformation. In this state, it can interact with
GluN2B-containing NMDARs, forming a CASK-SAP97-
NMDAR complex, and does not appreciably interact with
GluA1-containingAMPARs. Thus, CASK levels and the degree to
which CASK is bound to SAP97 can explain how SAP97 differ-
entially targets AMPARs and NMDARs at the ER (Fig. 4b). The
4
(Figure legend continued.) 1 m. f, The FRET efficiency of Ch-SAP97-V colocalized with
NMDARs inneurons. Left, Images of dendrites fromculturedhippocampal neurons (E18, 14DIV)
transfected with Ch-SAP97-V and immunolabeled with anti-GluN2B antibodies to detect en-
dogenous GluN2B colocalized with Ch-SAP97-V (Ch-SAP97-V fluorescence, top; anti-GluN2B,
middle; merged image, bottom). Scale bar, 10m. Middle, Expanded images of Ch-SAP97-V
puncta that colocalizewithGluN2B (arrow) or donot colocalize. Right, An example of analysis of
the donor fluorescence intensity profiles taken through the yellow line in the middle images.
Intensity profiles were acquired before (pre; solid line) and after (post; dashed line) acceptor
photobleaching. FRET changeswere only observed for Ch-SAP97-V puncta not colocalizedwith
GluN2B. Scale bar, 1 m. g, Ch-SAP97-V FRET efficiency values at AMPAR-or NMDAR-
containing puncta in dendrites. The FRET efficiency of Ch-SAP97-V in GluA1-associated puncta
was 27.2  1.6% and 5.2  1.4% for Ch-SAP97-V in puncta not associated with GluA1
(mean SEM;n53puncta, 8 cells, *p0.01). Ch-SAP97-V FRET efficiencywas3.51.2%
for puncta associated with GluN2B subunits and 26.2 1.5% for puncta not associated with
GluN2B (mean SEM; n 78 puncta, 10 cells, *p 0.01).
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Figure 3. CASK binding to SAP97 triggers a change in SAP97 conformation. a, Schematic of SAP97 and CASK L27 domain mutation constructs, L15K-Ch-SAP97-V and Myc-CASK-L27N. b,
Representative images of FRET analysis in HEK293 cells expressing the indicated Ch-SAP97-V and Myc-CASK constructs. Images of Ch-SAP97-V fluorescence are the initial and final (pre and post)
Venus andmCherry fluorescence signals acquired over the course of acceptor photobleaching. Myc-CASK was detected with anti-Myc antibodies (blue). Scale bar, 10m. c, CASK association with
Ch-SAP97-V decreases FRET efficiency. Ch-SAP97-V FRET efficiency was measured in HEK293 cells expressing the indicated Ch-SAP97-V and Myc-CASK constructs. When associated with CASK,
Ch-SAP97-V FRET efficiencywasdecreased from13.01%to2.21.5%(mean SEM,n20 cells, *p0.001). This decreasedoesnot occurwhenCASKL27N is substituted for CASK (13.6
0.7%; mean SEM, n 16 cells). When the L27 domain L15Kmutation was introduced to SAP97, only a partial decrease in L15K-Ch-SAP97-V FRET efficiency, from 12.7 0.7% to 8.5 0.6%
(mean SEM, n 18 cells), was observed when CASK was present. d, L27 domain mutations disrupt the interaction between SAP97 and CASK. Wild-type and mutated SAP97 and CASK were
coexpressed in HEK293 cells. Cell lysates were prepared, CASK-SAP97 complexes immunoprecipitatedwith anti-Myc antibody against the CASK tag and probedwith anti-GFP (SAP97) and anti-Myc
(CASK) antibodies. In the displayed representative Western blots, SAP97 only significantly coprecipitates with CASK when their respective L27 domains are intact. e, CASK coexpression dis-
rupts interactions between SAP97 and AMPARs. Cell lysates were prepared from HEK293 cells expressing Ch-GluA1 and GFP-SAP97 in the absence or presence of (Figure legend continues.)
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complex of CASK and SAP97 bound to NMDARs in the ER re-
cruits an additional set of binding partners that help mediate
subsequent events. These events include the formation of ER-
derived transport vesicles that contain ER-resident proteins as
well as the CASK-SAP97-NMDAR complex (Jeyifous et al.,
2009). In addition, CASK domains other than its L27N domain
mediate interactions with a set of proteins that recruits an addi-
tional set of binding partners that link GluN2B-containing
NMDARs to the kinesinmotor, KIF17 (Setou et al., 2000). KIF17
moves NMDAR transport vesicles on microtubules in dendrites
to a region near the synapse that the NMDARs will be trafficked
to.When not bound byCASK, SAP97 is stabilized in the compact
conformation that allows it to bind to AMPARs. Here it may play
a parallel role in AMPAR trafficking and help recruit a different
set of proteins linking it to another microtubule motor, such as
KIF5 (Setou et al., 2000), which trafficks AMPARs in transport
vesicles from the Golgi in the soma to their destinations in the
dendrites.
Once NMDAR and AMPAR transport vesicles arrive at
their destinations, they must disengage from microtubules
in the shaft of the dendrite to allow the receptors to traffick to
their specific postsynaptic membranes. We propose that a
switch in SAP97 conformation could play an important role in
synapse-specific targeting of NMDARs and AMPARs by caus-
ing the disengagement of cargo frommicrotubules andmotors
(Fig. 4). As shown in Figure 4, we assume that synaptic signal-
ing events reverse SAP97 conformation, from extended to
compact when bound to CASK and NMDARs, and from com-
pact to extended when bound to AMPARs. The SAP97 confor-
mation reversal, therefore, could result in NMDAR and
AMPAR transport vesicle disengagement from their specific
motors and microtubules. Subsequently, as shown in Figure
4b, NMDAR and AMPAR transport vesicles are free to engage
myosin motors to traffick via the actin cytoskeleton into
spines for synaptic targeting. The synaptic signaling events
4
(Figure legend continued.) Myc-CASK. Immunoprecipitationswereperformedwith anti-GFP,
specific for SAP97, and anti-RFP (GluA1) and anti-Myc (CASK) antibodies were used to probe
membrane blots. Representative Western blots show a decrease in the amount of GluA1 that
coprecipitates with SAP97 when CASK is coexpressed. Band intensities were normalized to
values obtained in the absence of CASK coexpression. In the presence of CASK, coprecipitated
GluA1 intensity decreased to0.160.02 (meanSEM,n3 independent experiments,p
0.001). f, Left graph, Peak FRET efficiency values for Ch-SAP97-V measured in HEK293 cells
versus neurons. The values are as follows: 14.51.0% (HEK293 cells), 25.95.4% (neurons),
and *p 0.01. Right graph, Peak FRET efficiency values for Ch-SAP97-V coexpressed with
mutated CaMKII in HEK293 cells. Displayed are the mean peak FRET efficiency for Ch-SAP97-V
alone, 12.5  0.5%; Ch-SAP97-V  CaMKII-T286A, 9.6  1.0%; Ch-SAP97-V  CaMKII-
T286D, 16.6 0.4%; *p 0.01, **p 0.05.
Figure 4. Model of SAP97 conformational changes, the role of CASK and the regulation of SAP97 interactionswith AMPARs and NMDARs. a, Proposed dynamic conformational changes of SAP97
in vivo. SAP97 is stabilized in the extended conformationwhen CASK binds to its L27 domain. The associations of the PDZ domains of SAP97 are changed by the transition from extended to compact
conformation. In the compact conformation, SAP97 associateswith thePDZbindingdomain of theAMPAR subunit, GluA1, and in the extended conformationwith theNMDAR subunit, GluN2B. CASK
unbinding from SAP97 reverses the conformational change back to the compact conformation and causes the release of the GluN2B subunit. b, Proposed role of SAP97 conformation in sorting,
trafficking, and synaptic targeting of NMDARs and AMPARs.
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that specifically target NMDAR and AMPAR transport vesi-
cles are unknown but may involve a “synaptic tagging” mech-
anism (Frey and Morris, 1998) and the synaptic activation of
CaMKII (Lisman et al., 2012), which is trafficked into den-
dritic shafts at activated synaptic spines (Lemieux et al., 2012).
Indeed, CaMKII phosphorylation of Mint1 correlates with the
release of the NMDAR-containing transport vesicles from
KIF17, a microtubule motor (Guillaud et al., 2008). CASK
associates with Mint1 and is part of the adaptor complex link-
ing NMDARs to KIF17 (Setou et al., 2000). CaMKII can alter
SAP97 conformation (Fig. 3f ), potentially altering its interac-
tion with NMDARs. CaMKII phosphorylation of SAP97,
which also complexes with CASK (Jeyifous et al., 2009), may
augment the role of Mint1 in the release of transport vesicles
by changing SAP97 from its extended to compact conforma-
tion and causing its release from NMDARs. CaMKII phos-
phorylation may also alter the interaction between SAP97 in
the compact conformation and AMPARs in their transport
vesicles by a similar mechanism.
An observation that appears to be at odds with the model is
that SAP97 associates with NMDARs containing GluN2B when
expressed without CASK in HEK293 cells (Fig. 2b; Jeyifous et al.,
2009). This association could occur without CASK stabilizing
SAP97 in the extended conformation via L27 domain-mediated
multimerization of SAP97 (Nakagawa et al., 2004) triggering the
change from compact to extended conformation, allowing it to
bind to NMDARs. Alternatively, equilibrium between SAP97
states, although heavily favoring the compact state, could allow
some SAP97 in a meta-stable extended state to interact with
NMDARs in the absence of CASK (Fig. 4a). In the presence of
NMDARs, which interact with extended SAP97, and in the ab-
sence of binding partners that stabilize SAP97 in the compact
conformation,much of the SAP97would end up interacting with
NMDARs. In support of the latter explanation are our findings
that CASK coprecipitates with SAP97 and GluN2B from brain
lysates, colocalizes with NMDARs and SAP97 in cultured neu-
rons, and CASK knockdown in cultured neurons has the same
effect on NMDAR trafficking as SAP97 knockdown (Jeyifous et
al., 2009). Also in support of this explanation is our finding that
the distribution of SAP97 and GluN2B-containing NMDARs is
very different when coexpressed with CASK. In the absence of
CASK, SAP97 and NMDARs form large colocalized structures in
the ER and fail to traffick to the cell surface. Addition of CASK
prevents the formation of the structures and allows SAP97 and
NMDARs to traffick to the cell surface, consistent with a signifi-
cant change in the SAP97-NMDAR interaction (Jeyifous et al.,
2009).
Our findings provide mechanistic insights into how SAP97
differentially engages and disengages with AMPARs and
NMDARs at the ER and on separate transport vesicles. The struc-
tural basis of the changes in SAP97 conformation remains to be
determined, as doeswhether similar conformational changes reg-
ulate other scaffolding proteins. We are currently focusing on
how conformation is regulated by various post-translational
modifications and how higher levels of regulation control these
modifications. The alteration of SAP97 conformation byCaMKII
(Fig. 3f) suggests that there are othermechanisms that regulate its
conformation.
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